Scratching Counteracts IL-13 Signaling by Upregulating the Decoy Receptor IL-13Rα2 in Keratinocytes

Int J Mol Sci. 2019 Jul 6;20(13):3324. doi: 10.3390/ijms20133324.

Abstract

The vicious itch-scratch cycle is a cardinal feature of atopic dermatitis (AD), in which IL-13 signaling plays a dominant role. Keratinocytes express two receptors: The heterodimeric IL-4Rα/IL-13Rα1 and IL-13Rα2. The former one transduces a functional IL-13 signal, whereas the latter IL-13Rα2 works as a nonfunctional decoy receptor. To examine whether scratch injury affects the expression of IL-4Rα, IL-13Rα1, and IL-13Rα2, we scratched confluent keratinocyte sheets and examined the expression of three IL-13 receptors using quantitative real-time PCR (qRT-PCR) and immunofluorescence techniques. Scratch injuries significantly upregulated the expression of IL13RA2 in a scratch line number-dependent manner. Scratch-induced IL13RA2 upregulation was synergistically enhanced in the simultaneous presence of IL-13. In contrast, scratch injuries did not alter the expression of IL4R and IL13RA1, even in the presence of IL-13. Scratch-induced IL13RA2 expression was dependent on ERK1/2 and p38 MAPK signals. The expression of IL-13Rα2 protein was indeed augmented in the scratch edge area and was also overexpressed in lichenified lesional AD skin. IL-13 inhibited the expression of involucrin, an important epidermal terminal differentiation molecule. IL-13-mediated downregulation of involucrin was attenuated in IL-13Rα2-overexpressed keratinocytes, confirming the decoy function of IL-13Rα2. Our findings indicate that scratching upregulates the expression of the IL-13 decoy receptor IL-13Rα2 and counteracts IL-13 signaling.

Keywords: IL-13; IL-13Rα1; IL-13Rα2; IL-4Rα; atopic dermatitis; involucrin; keratinocyte; scratch injury.

MeSH terms

  • Dermatitis, Atopic / pathology
  • Enzyme Activation / drug effects
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Humans
  • Interleukin-13 / metabolism*
  • Interleukin-13 Receptor alpha2 Subunit / metabolism*
  • Keratinocytes / drug effects
  • Keratinocytes / metabolism*
  • Protein Kinase Inhibitors / pharmacology
  • Protein Precursors / metabolism
  • Signal Transduction* / drug effects
  • Skin / pathology
  • Up-Regulation* / drug effects
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Interleukin-13
  • Interleukin-13 Receptor alpha2 Subunit
  • Protein Kinase Inhibitors
  • Protein Precursors
  • involucrin
  • Extracellular Signal-Regulated MAP Kinases
  • p38 Mitogen-Activated Protein Kinases